Wolfgang Miesbach: How Haemophilia Care Has Evolved in China
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on LinkedIn about a recent article by Yun Wang et al, published in RPTH Journal, adding։
”Same disease – different realities.
Just read a very insightful review by Xue, Poon, Yang and colleagues on how haemophilia care has evolved in China, and it really challenges the usual Euro‑/US‑centric perspective:
The authors describe how China has compressed decades of progress into a short time frame: building a nationwide tiered center network, scaling up domestic plasma‑derived and recombinant factors, introducing new non‑factor therapies, and pushing ahead with multiple AAV gene therapy programs – all while still grappling with underdiagnosis, marked urban–rural disparities, and substantial out‑of‑pocket burden for many patients.
What I find especially interesting is that China is not just copying Western models; strong national policy, local manufacturing, and home‑grown innovation (from rFVIIa and FX activators to anti‑TFPI and anti–protein C antibodies) are turning it into a rapidly emerging source of real‑world data, new drugs, and alternative care structures that could influence haemophilia management well beyond China.”
Title: The therapeutic landscape of inherited bleeding disorders in China
Authors: Yun Wang, Feng Xue, Man-Chiu Poon, Renchi Yang
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 13, 2026, 23:39Yaariv Khaykin: Whole-Person Care Can Strengthen Stroke Prevention in Patients With Atrial Fibrillation
-
Jul 13, 2026, 22:33ESOC 2026 recordings are now available on eSTEP – European Stroke Organisation
-
Jul 13, 2026, 20:17Julia R. Coleman: Fantastic First Day at ISTH 2026
-
Jul 13, 2026, 20:11Ruah Alyamany: Combination Therapy Improves Quality of Life in ITP
-
Jul 13, 2026, 19:47Brian O Mahony: Two-Year Results of BBM-H901 Gene Therapy Presented at ISTH 2026
-
Jul 13, 2026, 19:37Sara Zalghout: Connecting With Colleagues From All Over the World at ISTH 2026
-
Jul 13, 2026, 18:54Alfonso J. Tafur: New Evidence on Perioperative Anticoagulation in Cancer at ISTH 2026
-
Jul 13, 2026, 18:42Jessica Garcia: Thrombin Generation in Type 3 VWD With an Inhibitor on Emicizumab
-
Jul 13, 2026, 18:19Fionnuala Ní Áinle: High-Quality Evidence for DVT Diagnosis in Pregnancy at ISTH 2026